| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |